BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 10320618)

  • 1. Experimental Leishmania major infection in mice: role of IL-10.
    Chatelain R; Mauze S; Coffman RL
    Parasite Immunol; 1999 Apr; 21(4):211-8. PubMed ID: 10320618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of a Th2 population from a polarized Leishmania-specific Th1 population by in vitro culture with IL-4.
    Mocci S; Coffman RL
    J Immunol; 1995 Apr; 154(8):3779-87. PubMed ID: 7706719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of plasmids expressing interleukin-4 and interleukin-10 causes BALB/c mice to induce a T helper 2-type response despite the expected T helper 1-type response with a low-dose infection of Leishmania major.
    Yamakami K; Akao S; Tadakuma T; Nitta Y; Miyazaki J; Yoshizawa N
    Immunology; 2002 Apr; 105(4):515-23. PubMed ID: 11985672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute IL-4 Governs Pathogenic T Cell Responses during
    Poudel B; Yorek MS; Mazgaeen L; Brown SA; Kanneganti TD; Gurung P
    Immunohorizons; 2020 Sep; 4(9):546-560. PubMed ID: 32948646
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-leishmania effector functions of CD4+ Th1 cells and early events instructing Th2 cell development and susceptibility to Leishmania major in BALB/c mice.
    Louis JA; Conceiçao-Silva F; Himmelrich H; Tacchini-Cottier F; Launois P
    Adv Exp Med Biol; 1998; 452():53-60. PubMed ID: 9889959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KM(+), a lectin from Artocarpus integrifolia, induces IL-12 p40 production by macrophages and switches from type 2 to type 1 cell-mediated immunity against Leishmania major antigens, resulting in BALB/c mice resistance to infection.
    Panunto-Castelo A; Souza MA; Roque-Barreira MC; Silva JS
    Glycobiology; 2001 Dec; 11(12):1035-42. PubMed ID: 11805076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the production of soluble IL-4 receptors in murine cutaneous leishmaniasis. The roles of IL-12 and IL-4.
    Fernandez-Botran R; Chilton PM; Hondowicz BD; Vetvickova J; Yan J; Jones W; Scott P
    J Leukoc Biol; 1999 Sep; 66(3):481-8. PubMed ID: 10496319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to Leishmania major infection in interleukin-4-deficient mice.
    Noben-Trauth N; Kropf P; Müller I
    Science; 1996 Feb; 271(5251):987-90. PubMed ID: 8584936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different cytokines are required for induction and maintenance of the Th2 type response in DBA/2 mice resistant to infection with Leishmania major.
    Nashed BF; Maekawa Y; Takashima M; Zhang T; Ishii K; Dainichi T; Ishikawa H; Sakai T; Hisaeda H; Himeno K
    Microbes Infect; 2000 Oct; 2(12):1435-43. PubMed ID: 11099930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro model for infection with Leishmania major that mimics the immune response in mice.
    Soares MB; David JR; Titus RG
    Infect Immun; 1997 Jul; 65(7):2837-45. PubMed ID: 9199457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-4 induces a Th2 response in Leishmania major-infected mice.
    Chatelain R; Varkila K; Coffman RL
    J Immunol; 1992 Feb; 148(4):1182-7. PubMed ID: 1531351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
    Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
    J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
    Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
    Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of in vitro T helper cell type 1 to T helper cell type 2 switching in highly polarized Leishmania major-specific T cell populations.
    Mocci S; Coffman RL
    J Immunol; 1997 Feb; 158(4):1559-64. PubMed ID: 9029090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of IL-12-responsive CD4+ T cells during a Th2 response in Leishmania major-infected mice.
    Hondowicz BD; Park AY; Elloso MM; Scott P
    Eur J Immunol; 2000 Jul; 30(7):2007-14. PubMed ID: 10940890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Setting in motion the immune mechanisms underlying genetically determined resistance and susceptibility to infection with Leishmania major.
    Launois P; Conceiçao-Silva F; Himmerlich H; Parra-Lopez C; Tacchini-Cottier F; Louis JA
    Parasite Immunol; 1998 May; 20(5):223-30. PubMed ID: 9651923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity.
    Powrie F; Correa-Oliveira R; Mauze S; Coffman RL
    J Exp Med; 1994 Feb; 179(2):589-600. PubMed ID: 7905019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to Leishmania major in IL-4 transgenic mice is not correlated with the lack of a Th1 immune response.
    Erb KJ; Blank C; Moll H
    Immunol Cell Biol; 1996 Jun; 74(3):239-44. PubMed ID: 8799723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T helper 1 response against Leishmania major in pregnant C57BL/6 mice increases implantation failure and fetal resorptions. Correlation with increased IFN-gamma and TNF and reduced IL-10 production by placental cells.
    Krishnan L; Guilbert LJ; Wegmann TG; Belosevic M; Mosmann TR
    J Immunol; 1996 Jan; 156(2):653-62. PubMed ID: 8543817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.